A Clinical trial of Cystocal-SS40 tablet in Kidney stone.

An open label pilot study to evaluate the efficacy of Tablet Cystocal-SS40 in the management of Urinary Calculus - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085006

Enrollment

Registered

2025-04-16

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N209- Urinary calculus, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Urinary calculus 0 to 10 mm (diagnosed through USG) Pain and discomfort of lower abdomen Pain in back region Hesitancy or a feeling of inability to pass urine completely Hematuria (not associated with any renal pathology) Painful urination

Exclusion criteria

Exclusion criteria: Patient who requires acute medical care. Urinary calculus in Medulla of Kidney. Prostatic pathology like Chronic bacterial prostatitis, infection. Patients with known nephropathy. Patients pre-diagnosed in USG like polycystic kidney disease , patients on permanent renal replacement therapy (haemodialysis), Patients with history of kidney transplantation, Renal abscess. History of urinary tract surgery within 30 days before study entry Complete, permanent obstruction of the urinary tract.

Design outcomes

Primary

Measure	Time frame
The primary outcome would likely measure the effectiveness of treatment in relieving pain, burning and painful micturition. Timepoint: 30 days study with follow up on 7th, 20th and 30th Day	—

Secondary

Measure	Time frame
To observe drug safety & efficacyTimepoint: 30 days study with follow up on 7th 20th & 30th day	—

Countries

India

Contacts

Public ContactDr Madhulika D Tiwari

Dr. D Y Patil College of Ayurved and Research Centre

madhulika.tiwari@dpu.edu.in9158350066

Outcome results